 |
市场调查报告书
商品编码
1897633
分叉血管支架市场规模、份额和成长分析（按器械类型、材质、应用和地区划分）－2026-2033年产业预测Branched Stent Grafts Market Size, Share, and Growth Analysis, By Device Type (Aortic Branched Stent Grafts, Iliac Branched Stent Grafts), By Material (Nitinol, Polytetrafluoroethylene (PTFE)), By Application, By Region - Industry Forecast 2026-2033 |
||||||
全球分叉血管支架市场规模预计在 2024 年达到 3.4937 亿美元，从 2025 年的 3.7627 亿美元增长到 2033 年的 6.8112 亿美元，在预测期（2026-2033 年）内复合年增长率为 7.7%。
由于医疗技术的进步、血管内介入治疗（EVAR）手术量的增加以及患者照护品质的提高，全球分支血管支架市场正经历显着增长。人口老化加剧以及主动脉瘤和腹部主动脉血管瘤的高发生率进一步推动了市场扩张。此外，微创手术技术的普及也为市场发展提供了巨大机会。儘管全球卫生危机期间择期手术的延迟等医疗服务中断带来了挑战，但对分支血管支架的整体需求仍在持续成长。这项创新技术拓展了主动脉病变的治疗范围，凸显了其在现代血管介入治疗中的关键作用，使其在未来的医疗保健领域拥有强劲的成长潜力。
推动全球分支血管支架市场发展的因素
分支型血管支架市场受到血管内动脉瘤修復术（EVAR）数量不断增加、患者照护品质不断提高以及医疗技术持续进步的显着影响。此外，人口老化和腹部主动脉血管瘤（AAA）发生率上升也促进了该市场的扩张。这些因素共同推动了血管疾病治疗领域对创新解决方案的强劲需求，进而推动了全球分支型血管支架市场的成长与发展。随着医疗保健的不断发展，该市场有望迎来进一步的进步和更广泛的应用。
限制全球分支支架血管支架市场的因素
全球分支血管支架市场面临严峻挑战，主要原因是血管内动脉瘤修復手术费用高。这一经济障碍限制了中低收入患者获得治疗的机会，使他们难以负担必要的治疗费用。由于相当一部分人群无法获得先进的医疗干预，这些手术的高昂费用成为市场成长的主要阻碍因素。因此，这种限制性的价格动态阻碍了分支血管支架在血管疾病治疗中的广泛应用，进而影响了整体市场潜力。
分支支架血管支架市场的全球趋势
全球分支血管支架市场呈现显着上升趋势，这主要得益于血管疾病盛行率的不断攀升以及微创手术技术的日益普及。腹主动脉瘤腔内修復术（AEVAR）、分支血管瘤腔内修復术（BEVAR）和胸主动脉瘤腔内修復术（TEVAR）等治疗方法因其安全性、有效性、成本效益以及显着缩短手术时间的优势而备受关注。包括X射线在内的先进影像引导技术的应用，提高了手术精度和治疗效果，进一步推动了市场成长。随着患者意识的不断提高和技术的进步，分支血管支架市场前景仍然强劲且充满希望。
目录
介绍
- 调查目标
- 调查范围
- 定义
调查方法
- 资讯收集
- 二手资料和一手资料方法
- 市场规模预测
- 市场假设与限制
执行摘要
- 全球市场展望
- 供需趋势分析
- 细分市场机会分析
市场动态与展望
- 市场规模
- 市场动态
- 驱动因素和机会
- 限制与挑战
- 波特分析
关键市场考察
- 关键成功因素
- 竞争程度
- 关键投资机会
- 市场生态系统
- 市场吸引力指数（2025）
- PESTEL 分析
- 总体经济指标
- 价值链分析
- 定价分析
- 监管分析
全球分支支架血管支架市场规模（按器械类型和复合年增长率划分）（2026-2033 年）
- 主动脉分叉血管支架
- 髂动脉分叉支架血管支架
- 股动脉分支血管支架
- 全球分支支架血管支架市场规模（按材料和复合年增长率划分）（2026-2033 年）
- 镍钛诺
- 聚四氟乙烯（PTFE）
- 聚酯纤维
全球分支支架血管支架市场规模（按应用及复合年增长率划分）（2026-2033 年）
- EVAR
- 烟囱
- 开窗式血管内主动脉瘤修復术
- 其他的
全球分支支架血管支架市场规模及复合年增长率（2026-2033）
- 北美洲
- 美国
- 加拿大
- 欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
- 亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
- 拉丁美洲
- 巴西
- 其他拉丁美洲地区
- 中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区
竞争资讯
- 前五大公司对比
- 主要企业的市场定位（2025 年）
- 主要市场参与者所采取的策略
- 近期市场趋势
- 公司市占率分析（2025 年）
- 主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2021-2023年营收年比比较
主要企业简介
- Medtronic plc
- Cook Medical
- WL Gore & Associates, Inc.
- Endologix, Inc.
- JOTEC GmbH
- LeMaitre Vascular, Inc.
- MicroPort Scientific Corporation
- Terumo Corporation
- Vascutek, Ltd.
- Zenith（Cook Medical）
- TriVascular Technologies, Inc.
- Bolton Medical
- Lombard Medical, Inc.
- QualiMed Innovative Medizinprodukte GmbH
- Nano Endoluminal, SL
结论与建议
Global Branched Stent Grafts Market size was valued at USD 349.37 Million in 2024 and is poised to grow from USD 376.27 Million in 2025 to USD 681.12 Million by 2033, growing at a CAGR of 7.7% during the forecast period (2026-2033).
The global branched stent graft market is experiencing significant growth driven by advancements in medical technology, an increase in endovascular cardiovascular disease repair (EVAR) procedures, and enhanced patient care quality. The rise in the elderly population and the high incidence of aortic and abdominal aneurysms are further fueling market expansion. Additionally, the trend toward minimally invasive surgical techniques presents considerable opportunities for market development. Despite challenges posed by disruptions in healthcare services, such as postponed elective surgeries during global health crises, the overall demand for branched stent grafts continues to rise. This innovative technology expanding the treatment scope for aortic lesions underscores its critical role in modern vascular interventions, positioning it strongly for future growth within the healthcare landscape.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Branched Stent Grafts market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Branched Stent Grafts Market Segments Analysis
Global Branched Stent Grafts Market is segmented by device type, material, application and region. Based on device type, the market is segmented into aortic branched stent grafts, iliac branched stent grafts and femoral branched stent grafts. Based on material, the market is segmented into nitinol, polytetrafluoroethylene (PTFE) and polyester. Based on application, the market is segmented into EVAR, chimney, fenestrated endovascular aortic aneurysm repair and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Branched Stent Grafts Market
The branched stent grafts market is significantly influenced by an increase in endovascular aneurysm repair (EVAR) procedures, enhancements in the quality of patient care, and the ongoing advancements in medical technology. Additionally, the aging population and the rising incidence of abdominal aortic aneurysms (AAA) are contributing to the expansion of this market. These factors collectively create a strong demand for innovative solutions in the treatment of vascular conditions, thereby propelling the growth and development of branched stent grafts within the global medical landscape. As healthcare continues to evolve, the market is poised for further advancements and increased adoption.
Restraints in the Global Branched Stent Grafts Market
The global branched stent grafts market faces notable challenges due to the high costs associated with endovascular aneurysm repair procedures. This financial barrier limits access for individuals from middle and lower-income backgrounds, making it difficult for them to afford the necessary treatments. The significant expenses involved in these procedures serve as a substantial constraint on market growth, as a considerable segment of the population is unable to pursue advanced medical interventions. Consequently, the restrictive pricing dynamics hinder wider adoption and utilization of branched stent grafts in treating vascular ailments, impacting overall market potential.
Market Trends of the Global Branched Stent Grafts Market
The Global Branched Stent Grafts market is witnessing a notable upward trend, driven by the increasing prevalence of vascular diseases and the growing acceptance of minimally invasive surgical techniques. Treatments such as abdominal endovascular aneurysm repair (AEVAR), branched endovascular aneurysm repair (BEVAR), and thoracic endovascular aneurysm repair (TEVAR) have gained prominence due to their safety, efficacy, and cost-effectiveness, significantly reducing operative times. The integration of advanced imaging guidance technologies, including X-rays, enhances procedural accuracy and outcomes, further propelling market growth. As patient awareness and technological advancements continue to rise, the outlook for branched stent grafts remains robust and promising.
Table of Contents
Introduction
- Objectives of the Study
- Scope of the Report
- Definitions
Research Methodology
- Information Procurement
- Secondary & Primary Data Methods
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Global Market Outlook
- Supply & Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Overview
- Market Size
- Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
- Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers
Key Market Insights
- Key Success Factors
- Degree of Competition
- Top Investment Pockets
- Market Ecosystem
- Market Attractiveness Index, 2025
- PESTEL Analysis
- Macro-Economic Indicators
- Value Chain Analysis
- Pricing Analysis
- Regulatory Analysis
Global Branched Stent Grafts Market Size by Device Type & CAGR (2026-2033)
- Market Overview
- Aortic Branched Stent Grafts
- Iliac Branched Stent Grafts
- Femoral Branched Stent Grafts
- Global Branched Stent Grafts Market Size by Material & CAGR (2026-2033)
- Market Overview
- Nitinol
- Polytetrafluoroethylene (PTFE)
- Polyester
Global Branched Stent Grafts Market Size by Application & CAGR (2026-2033)
- Market Overview
- EVAR
- Chimney
- Fenestrated Endovascular Aortic Aneurysm Repair
- Others
Global Branched Stent Grafts Market Size & CAGR (2026-2033)
- North America (Device Type, Material, Application)
- US
- Canada
- Europe (Device Type, Material, Application)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Device Type, Material, Application)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Device Type, Material, Application)
- Brazil
- Rest of Latin America
- Middle East & Africa (Device Type, Material, Application)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)
Key Company Profiles
- Medtronic plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cook Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- W. L. Gore & Associates, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Endologix, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- JOTEC GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LeMaitre Vascular, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- MicroPort Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Terumo Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Vascutek, Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Zenith (Cook Medical)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- TriVascular Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bolton Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lombard Medical, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- QualiMed Innovative Medizinprodukte GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nano Endoluminal, S.L.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
主动脉血管支架市场规模、份额和成长分析（按产品、最终用户和地区划分）—产业预测（2026-2033 年）
自动扩张型支架：全球市场份额和排名、总收入和需求预测（2025-2031年）
全球支架置入和扩张器材市场：市场规模、份额和趋势分析（2025-2032 年）
主动脉血管支架市场（依动脉瘤部位、移植物类型、配置、植入机制、最终用户、入路和材料划分）－2025-2032年全球预测血管支架市场按产品类型、适应症、最终用户、输送机制、材料和配置划分－2025-2032 年全球预测
主动脉支架移植物市场
2025年主动脉血管支架全球市场报告2025年全球主动脉内皮移植市场报告2025年全球自膨式支架市场报告
全球自动扩张型支架市场